References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Dorretal(2005)Maraviroc(UK-427,857),apotent,orallybioavailable,andselectivesmall-moleculeinhibitorofchemokinereceptorCCR5withbroad-spectrumanti-humanimmunodeficiencyvirustype1activity.Antimicrob.AgentsChemother.494721PMID:16251317
Garcia-Perezetal(2011)NewinsightsintothemechanismswherebylowmolecularweightCCR5ligandsinhibitHIV-1infection.J.Biol.Chem.2864978PMID:21118814
Kuritzkesetal(2008)Freshfromthepipeline-maraviroc.Nat.Rev.DrugDiscov.715PMID:
Piotrowskaetal(2016)Maravirocreducesneuropathicpainthroughpolarizationofmicrogliaandastroglia-Evidencefrominvivoandinvitrostudies.NeuropharmacologyS0028-390830164PMID:27117708
Keywords:Maraviroc,supplier,UK-427857,HIV-1,gp120,CCR5,chemokine,receptors,ligands,selective,antagonists,HIV,Rantes,UK-427857,Antivirals,Chemokine,CC,Receptors,Chemokine,CC,Receptors,TocrisBioscience